Biotech is back! After a rough 2016, the biopharmaceutical industry has regained momentum to become one of the fastest growing sectors of 2017. The benchmark iShares Nasdaq Biotechnology ETF (IBB) has racked up a year-to-date return of 12%, compared to 5.9% for the S&P 500 (SPY) .
